Evaluation of the Safety of Rapid Administration of Undiluted High-Dose Intravenous Levetiracetam (vol 12, pg 227, 2022)

被引：0
|
作者：
Brittany, Kasturiarachi M.
Krishnan, Rashi
Diana, Alsbrook L.
Brittany, Hudson
Hallie, Kelly
Caitlin, Moran E.
Khalid, Alsherbini
Morgan, Jones G.
机构：
来源：
NEUROHOSPITALIST | 2023年 / 13卷 / 01期
关键词：
D O I：
10.1177/19418744221118895
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 47 条
  • [21] Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis (vol 18, pg 34, 2008)
    Saito, Eizo
    Koike, Takao
    Hashimoto, Hiroshi
    Miyasaka, Nobuyuki
    Ikeda, Yasuo
    Hara, Masako
    Yamada, Hidehiro
    Yoshida, Tadashi
    Harigai, Masayoshi
    Ichikawa, Yoichi
    [J]. MODERN RHEUMATOLOGY, 2008, 18 (02) : 212 - 212
  • [22] EFFECTIVENESS OF HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN THERAPY IN ACQUIRED VON-WILLEBRANDS-DISEASE (VOL 67, PG 14, 1994)
    VANGENDEREN, PJJ
    [J]. VOX SANGUINIS, 1994, 67 (03) : 322 - 322
  • [23] SINGLE-DOSE INTRAVENOUS ADMINISTRATION OF ANTIEPILEPTIC DRUGS INDUCES RAPID AND REVERSIBLE REMODELING IN THE BRAIN: EVIDENCE FROM A VOXEL-BASED MORPHOMETRY EVALUATION OF VALPROATE AND LEVETIRACETAM IN RHESUS MONKEYS
    Tang, Y.
    Yu, X.
    Zhang, X.
    Xia, W.
    Wu, X.
    Zou, X.
    Li, H.
    Huang, X.
    Stefan, H.
    Chen, Q.
    Gong, Q.
    Zhou, D.
    [J]. NEUROSCIENCE, 2015, 303 : 595 - 603
  • [24] Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis (vol 5, pg 2142, 2021)
    Jeong, H.
    Cho, H.
    Kim, H.
    [J]. BLOOD ADVANCES, 2023, 7 (04) : 560 - 560
  • [25] Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - Report of the National Multicenter Trial (vol 97, pg 7, 1996)
    Rennels
    Fries, S
    Froehlich, H
    [J]. PEDIATRICS, 1996, 98 (01) : A38 - A38
  • [26] Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study. (vol 139, pg.no 2747, 2022)
    Roussel, M.
    Lauwers-Cances, V
    Macro, M.
    [J]. BLOOD, 2023, 141 (10) : 1234 - 1234
  • [27] Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer (vol 13, pg 2100, 2007)
    van der Vliet, H. J.
    Koon, H. B.
    Yue, S. C.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (11) : 3433 - 3433
  • [28] Association Between Early Administration of High-Dose Erythropoietin in Preterm Infants and Brain MRI Abnormality at Term-Equivalent Age (vol 312, pg 817, 2014)
    Leuchter, Russia Ha-Vinh
    Gui, Laura
    Poncet, Antoine
    Hagmann, Cornelia
    Lodygensky, Gregory Anton
    Martin, Ernst
    Koller, Brigitte
    Darque, Alexandra
    Bucher, Hans Ulrich
    Hueppi, Petra Susan
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (08): : A817 - A817
  • [29] Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study (vol 384, pg 504, 2014)
    Lynch, D. R.
    Fischbeck, K. H.
    [J]. LANCET, 2014, 384 (9942): : 494 - 494
  • [30] High-dose intravenous immunoglobulin does not reduce the numbers of circulating CD14+CD16++ monocytes in patients with inflammatory disorders (vol 145, pg 11, 2012)
    Tjon, Angela S. W.
    Metselaar, Herold J.
    te Boekhorst, Peter A. W.
    van Hagen, P. Martin
    Kwekkeboom, Jaap
    [J]. CLINICAL IMMUNOLOGY, 2013, 147 (01) : 69 - 69
12345